---
figid: PMC8123861__ijms-22-04558-g001
figtitle: PGC-1A in the Mitochondrial NAD+ Pool in Metabolic Diseases
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Saccharomyces cerevisiae
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC8123861
filename: ijms-22-04558-g001.jpg
figlink: /pmc/articles/PMC8123861/figure/ijms-22-04558-f001/
number: F1
caption: PGC-1α is involved in the pathway of NAD+ biosynthesis and consumption in
  the metabolic tissue such as muscle, liver, and adipose tissue. (A). NAD+ de novo
  synthesis from Trp. PGC-1α may promote QA synthesis via blocking ACMSD. PGC-1α1
  may promote de novo synthesis via KAT activation. (B). NAD+ biosynthesis from NA
  in the Preiss–Handler pathway; QA from de novo synthesis also can be synthesized
  to NAD+ in the Preiss–Handler pathway. (C). PGC-1α may influence many enzymes in
  the salvage pathway. ACMS, α-amino-β-carboxymuconate-ε-semialdehyde; ACMSD, ACMS
  decarboxylase; NAMPT, nicotinamide phosphoribosyltransferases (three isoforms exist);
  NMNAT, NMN adenylyltransferase; PARP, poly (ADP-ribose) polymerase. Dashed lines
  indicate additional evidence is required to reveal the mechanisms.
papertitle: Role of PGC-1α in the Mitochondrial NAD+ Pool in Metabolic Diseases.
reftext: Jin-Ho Koh, et al. Int J Mol Sci. 2021 May;22(9):4558.
year: '2021'
doi: 10.3390/ijms22094558
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: mitochondria | PGC-1α | NAD+, SIRTs | metabolic disease
automl_pathway: 0.9398608
figid_alias: PMC8123861__F1
figtype: Figure
redirect_from: /figures/PMC8123861__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8123861__ijms-22-04558-g001.html
  '@type': Dataset
  description: PGC-1α is involved in the pathway of NAD+ biosynthesis and consumption
    in the metabolic tissue such as muscle, liver, and adipose tissue. (A). NAD+ de
    novo synthesis from Trp. PGC-1α may promote QA synthesis via blocking ACMSD. PGC-1α1
    may promote de novo synthesis via KAT activation. (B). NAD+ biosynthesis from
    NA in the Preiss–Handler pathway; QA from de novo synthesis also can be synthesized
    to NAD+ in the Preiss–Handler pathway. (C). PGC-1α may influence many enzymes
    in the salvage pathway. ACMS, α-amino-β-carboxymuconate-ε-semialdehyde; ACMSD,
    ACMS decarboxylase; NAMPT, nicotinamide phosphoribosyltransferases (three isoforms
    exist); NMNAT, NMN adenylyltransferase; PARP, poly (ADP-ribose) polymerase. Dashed
    lines indicate additional evidence is required to reveal the mechanisms.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TWIST2
  - PPARGC1A
  - DLX3
  - TDO2
  - IDO1
  - PTPN5
  - ACMSD
  - NMNAT1
  - NMNAT3
  - NMNAT2
  - STAC3
  - BST1
  - CD38
  - NAMPT
  - Mat1a
  - Ppargc1a
  - Tdo2
  - Ido1
  - Ptpn5
  - Acmsd
  - Nmnat1
  - Nmnat3
  - Nmnat2
  - Bst1
  - Cd38
  - Nampt
  - ams
  - srl
  - de
  - .na.character
  - step
  - na
  - Nmnat
  - ppargc1a
  - ido1
  - acmsd
  - nmnat1
  - nmnat3
  - nmnat2
---
